Literature DB >> 26831547

Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.

Balázs Nemes1, György Gámán2, Wojciech G Polak3, Fanni Gelley4, Takanobu Hara5, Shinichiro Ono5, Zhassulan Baimakhanov5, Laszlo Piros2, Susumu Eguchi5.   

Abstract

Extended-criteria donors (ECDs) have an impact on early allograft dysfunction (EAD), biliary complications, relapse of hepatitis C virus (HCV), and survivals. Early allograft dysfunction was frequently seen in grafts with moderate and severe steatosis. Donors after cardiac death (DCD) have been associated with higher rates of graft failure and biliary complications compared to donors after brain death. Extended warm ischemia, reperfusion injury and endothelial activation trigger a cascade, leading to microvascular thrombosis, resulting in biliary necrosis, cholangitis, and graft failure. The risk of HCV recurrence increased by donor age, and associated with using moderately and severely steatotic grafts. With the administration of protease inhibitors sustained virological response was achieved in majority of the patients. Donor risk index and EC donor scores (DS) are reported to be useful, to assess the outcome. The 1-year survival rates were 87% and 40% respectively, for donors with a DS of 0 and 3. Graft survival was excellent up to a DS of 2, however a DS >2 should be avoided in higher-risk recipients. The 1, 3 and 5-year survival of DCD recipients was comparable to optimal donors. However ECDs had minor survival means of 85%, 78.6%, and 72.3%. The graft survival of split liver transplantation (SLT) was comparable to that of whole liver orthotopic liver transplantation. SLT was not regarded as an ECD factor in the MELD era any more. Full-right-full-left split liver transplantation has a significant advantage to extend the high quality donor pool. Hypothermic oxygenated machine perfusion can be applied clinically in DCD liver grafts. Feasibility and safety were confirmed. Reperfusion injury was also rare in machine perfused DCD livers.

Entities:  

Keywords:  Liver transplantation; biliary complication; extended-criteria donor; hepatitis C; initial poor function; ischemia; living related transplantation; machine perfusion; recurrence; reperfusion; split liver; survival

Mesh:

Year:  2016        PMID: 26831547     DOI: 10.1586/17474124.2016.1149062

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  23 in total

1.  Postoperative Elevated Resistive Indices Do Not Predict Hepatic Artery Thrombosis in Extended Criteria Donor Livers.

Authors:  Eric J Siskind; Fauzia Vandermeer; Tamar R Siskind; David A Bruno; Samuel Sultan; Josue Alvarez-Casas; Arielle Stafford; Barton Lane; John C Lamattina; Rolf N Barth; Steven I Hanish
Journal:  Int J Angiol       Date:  2017-03-01

2.  High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation.

Authors:  Eliza W Beal; Sylvester M Black; Khalid Mumtaz; Don Hayes; Ashraf El-Hinnawi; Kenneth Washburn; Dmitry Tumin
Journal:  Dig Dis Sci       Date:  2017-06-01       Impact factor: 3.199

3.  Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series.

Authors:  Vittorio Cherchi; Luigi Vetrugno; Giovanni Terrosu; Victor Zanini; Marco Ventin; Riccardo Pravisani; Francesco Tumminelli; Pier Paolo Brollo; Erica Boscolo; Roberto Peressutti; Dario Lorenzin; Tiziana Bove; Andrea Risaliti; Umberto Baccarani
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

4.  Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver Transplantation.

Authors:  Esteban Fuentes-Valenzuela; Javier Tejedor-Tejada; Félix García-Pajares; Beatriz M Rubiales; Rodrigo Nájera-Muñoz; Carlos Maroto-Martín; Laura Sánchez-Delgado; Carmen Alonso-Martín; Carolina A Álvarez; Gloria Sánchez-Antolín
Journal:  J Clin Exp Hepatol       Date:  2022-01-04

5.  A Small Animal Model of Ex Vivo Normothermic Liver Perfusion.

Authors:  Eliza W Beal; Curtis Dumond; Jung-Lye Kim; Clifford Akateh; Emre Eren; Katelyn Maynard; Chandan K Sen; Jay L Zweier; Kenneth Washburn; Bryan A Whitson; Sylvester M Black
Journal:  J Vis Exp       Date:  2018-06-27       Impact factor: 1.355

6.  The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.

Authors:  Karen L Thomsen; Francis P Robertson; Peter Holland-Fischer; Brian R Davidson; Rajeshwar P Mookerjee; Holger J Møller; Rajiv Jalan; Henning Grønbæk
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

Review 7.  Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.

Authors:  Judith Kahn; Peter Schemmer
Journal:  Visc Med       Date:  2018-10-30

Review 8.  Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.

Authors:  Elisabetta Loggi; Fabio Conti; Alessandro Cucchetti; Giorgio Ercolani; Antonio Daniele Pinna; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

Review 9.  Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis.

Authors:  Ágnes Lilla Szilágyi; Péter Mátrai; Péter Hegyi; Eszter Tuboly; Daniella Pécz; András Garami; Margit Solymár; Erika Pétervári; Márta Balaskó; Gábor Veres; László Czopf; Bastian Wobbe; Dorottya Szabó; Juliane Wagner; Petra Hartmann
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

10.  Opportunities for Therapeutic Intervention During Machine Perfusion.

Authors:  Negin Karimian; Heidi Yeh
Journal:  Curr Transplant Rep       Date:  2017-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.